Market Closed

RNXT
RenovoRx
$ 1.04
-10.34%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago

RenovoRx News

Latest RenovoRx Stock News & RNXT Headlines

RenovoRx Q3 Earnings Call Highlights
9 days ago | marketbeat.com
RenovoRx, Inc. (RNXT) Q3 2026 Earnings Call Transcript
10 days ago | seekingalpha.com
RenovoRx, Inc. (RNXT) Reports Q3 Loss, Tops Revenue Estimates
10 days ago | zacks.com
RenovoRx to Participate at the Canaccord Genuity MedTech Diagnostics and Digital Health & Services Forum
19 days ago | globenewswire.com
RenovoRx to Report Third Quarter 2026 Financial Results and Business Highlights on November 5, 2026
25 days ago | globenewswire.com
RenovoRx Advances TAMP™ into Borderline Resectable Pancreatic Cancer with First Patient Enrolled in Investigator-Initiated PRISM-TAMP Trial
a month ago | globenewswire.com
RenovoRx Announces Peer-Reviewed Publication Highlighting the TAMP™ Platform's Potential to Improve Chemotherapeutic Delivery for Locally Advanced Pancreatic Cancer
a month ago | globenewswire.com
RenovoRx, Inc. (NASDAQ:RNXT) Stock Short Interest Jumps 55.7%
a month ago | defenseworld.net
RenovoRx to Present at H.C. Wainwright 28th Annual Global Investment Conference, September 14th-16th
2 months ago | globenewswire.com
RenovoRx Highlights Peer-Reviewed Publication of Pharmacokinetic and Pharmacodynamic (PK/PD) Data Supporting TAMP™ Platform's Targeted Drug-Delivery in Locally Advanced Pancreatic Cancer
3 months ago | globenewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

RNXT
RenovoRx
$ 1.04
-10.34%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago